| ¿µ¹® | amylase | ÇÑ±Û | ¾Æ¹Ð¶ó¾ÆÁ¦, ¾Æ¹Ð·¹À̽º |
|---|---|---|---|
| ¼³¸í | ´çÀº ´ÙÀ½°ú °°ÀÌ 3°¡Áö·Î ±¸ºÐµÈ´Ù. ´çÀÌ ÇѰ³ÀÎ ´Ü´ç·ù, ´Ü´ç·ù°¡ 3~6Á¤µµ ¿¬°áµÇ¾î ÀÖ´Â ¿Ã¸®°í´ç·ù, ±×¸®°í ¿Ã¸®°í´ç·ù ¿©·¯°³°¡ ¿¬°áµÇ¾î ÀÖ´Â ´Ù´ç·ù°¡ ±×°ÍÀÌ´Ù. ¾Æ¹Ð¶ó¾ÆÁ¦´Â ´Ù´ç·ùÀÇ ¿¬°áÀ» ²÷´Â È¿¼Ò·Î½á ħ°ú ÀÌÀÚ¿¡¼ ºÐºñµÇ´Â ¼ÒȾ׿¡ ¸¹´Ù. ±× ¿Ü¿¡µµ ¿©·¯ °¡Áö Á¶Á÷¿¡ ºÐÆ÷ÇÑ´Ù. ÀÌ È¿¼ÒÀÇ Ç÷Áß ³óµµ´Â ħ»ùÀÇ º´, ƯÈ÷ ħ»ù¿°ÁõÀÌ ÀÖÀ» ¶§ Áõ°¡ÇÏ°í ±Þ¼ºÀÌÀÚ¿°ÀÇ Áø´Ü¿¡µµ µµ¿òÀ» ÁØ´Ù. |
||
| ¿µ¹® | clearance | ÇÑ±Û | û¼Ò |
|---|---|---|---|
| ¼³¸í | ´ÜÀ§½Ã°£¿¡ ¾î¶² ¹°ÁúÀÌ ºÐºñ±â°üÀ» ÅëÇÏ¿© Ç÷¾×¿¡¼ Á¦°ÅµÇ´Â Çö»ó ȤÀº Á¦°ÅÇÒ ¼ö ÀÖ´Â ´É·Â. Ä¡°ú¿ë¾î·Î´Â Áö´ëÄ¡ Çü¼ºµÈ Ä¡¾ÆÀÇ ±³ÇÕ¸é°ú ´ëÇÕÄ¡ ±³ÇÕ¸é°úÀÇ °Å¸® ¶Ç´Â ´ëÇÕÄ¡ ±³Çո鰣ÀÇ °Å¸®¸¦ ÁÖ·Î ³ªÅ¸³»°í, ±âŸ ¼·Î ¸¶ÁÖº¸°í ÀÖ´Â ¹°Ã¼°£ÀÇ °Å¸®¸¦ ³ªÅ¸³¾ °æ¿ì¿¡µµ Àû¿ëµÈ´Ù. |
||
| ¿µ¹® | creatinine clearance | ÇÑ±Û | Å©·¹¾ÆÆ¼´Ñ û¼Ò |
|---|---|---|---|
| ¼³¸í | û¼Ò(clearance)¶õ ÇǼӿ¡¼ ¾î¶² ¹°ÁúÀ» Á¦°ÅÇÏ´Â ¼Óµµ¸¦ ÀǹÌÇÑ´Ù. ÇǼӿ¡¼ ¾î¶² ¹°ÁúÀ» Á¦°ÅÇÏ´Â °ÍÀº ÁÖ·Î ÄáÆÏÀÇ ¿ªÇÒÀ̹ǷΠÄáÆÏ¿¡¼ÀÇ ¾î¶² ¹°ÁúÀÌ Á¦°ÅµÇ´Â û¼ÒÀ²ÀÌ ÀÓ»óÀûÀ¸·Î Áß¿äÇÏ´Ù. ÄáÆÏ¿¡¼ÀÇ ¾î¶² ¹°ÁúÀÇ Ã»¼ÒÀ²Àº ´ÙÀ½°ú °°Àº ½ÄÀ¸·Î ±¸ÇØÁø´Ù. C(creatinine clearance) = V ¡¿ U / P C¶õ ÄáÆÏÀÇ Ã»¼ÒÀ²ÀÇ ¾àÀÚÀ̰í V´Â 1ºÐ´ç ³ª¿À´Â ¼Òº¯ÀÇ ¾çÀ¸·Î ml/minÀ̶õ ´ÜÀ§·Î Ç¥½ÃÇÑ´Ù. ±×¸®°í U¶õ ¼Òº¯¿¡ µé¾î Àִ û¼ÒÀ² ÃøÁ¤ÀÇ ´ë»óÀÌ µÇ´Â ¹°ÁúÀÇ ³óµµÀÌ´Ù. P¶õ û¼ÒÀ² ÃøÁ¤ÀÇ ´ë»óÀÌ µÇ´Â ¹°ÁúÀÇ Ç÷¾× ÁßÀÇ ³óµµ¸¦ ³ªÅ¸³½´Ù. Å©·¹¾ÆÆ¼´Ñ û¼Ò¶õ Å©·¹¾ÆÆ¾À̶ó´Â ¹°ÁúÀÇ Ã»¼ÒÀ²À» ³ªÅ¸³»´Â ¸»·Î ÄáÆÏ ±â´ÉÀÇ Æò°¡¿¡ ¸¹ÀÌ »ç¿ëµÇ´Â ÁöÇ¥ÀÌ´Ù. |
||
| ACR | Amylase-Creatinine Clearance Ratio &... |
|---|---|
| ACCR | amylase-creatinine clearance ratio |
| Cam | amylase clearance |
| AIA | allylisopropylacetamide; amylase inhibitor activity; anti-immunoglobulin antibody; anti-insulin anti... |
| AMS | ablepharon-microstomia syndrome; acute mountain sickness; adenosylmethionine synthetase; aggravated ... |
| ACCR | Amylase-creatinine clearance ratio |
|---|---|
| AMY | Amylase |
| Am | Amylase |
| TA-A | Taka-amylase A |
| UA | Urinary amylase |
| amylase-creatinine clearance ratio | A test for the diagnosis of acute pancreatitis; it is determined by measuring amylase and creatinine in serum and urine in apparently healthy individuals the renal clearance of amylase is less than 5% that of creatinine; in acute pancreatitis the ratio is said to be greater than 0.05 or 5%. (05 Mar 2000) |
|---|---|
| alpha-amylase | <enzyme> An enzyme that catalyses the endohydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides containing 3 or more 1,4-alpha-linked d-glucose units. Pharmacological action: anti-inflammatory agents. Chemical name: 1,4-alpha-D-Glucan glucanohydrolase Registry number: EC 3.2.1.1 (12 Dec 1998) |
| amylase | <enzyme> An enzyme produced in the pancreas and salivary glands. Elevation of the blood amylase is common in conditions of pancreatitis. (27 Sep 1997) |
| beta-amylase | <enzyme> An enzyme that catalyses the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. Chemical name: 1,4-alpha-D-Glucan maltohydrolase Registry number: EC 3.2.1.2 (12 Dec 1998) |
| gamma-amylase | A hydrolase removing terminal alpha-1,4-linked d-glucose residues from nonreducing ends of chains, with release of beta-d-glucose. Synonym: acid maltase, amyloglucosidase, gamma-amylase, glucoamylase. (05 Mar 2000) |
| maltotriose-forming amylase | <enzyme> Also carries out transglycosylation, forming p-nitrophenyl alpha-maltotetraoside from maltotetraose and p-nitrophenyl alpha-d-glucopyranoside Registry number: EC 3.2.1.- Synonym: g3-amylase (26 Jun 1999) |
| glycosylated alpha-amylase | <enzyme> Contains a single biantennary n-linked oligosaccharide that terminates with the structure fucalpha1,3(galbeta1,4)glcnac Registry number: EC 3.2.1.- Synonym: human glycosylated alpha-amylase (26 Jun 1999) |
| saccharogen amylase | <enzyme> An enzyme that catalyses the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. Chemical name: 1,4-alpha-D-Glucan maltohydrolase Registry number: EC 3.2.1.2 (12 Dec 1998) |
| ANP clearance receptors | Cell surface proteins that bind atrial natriuretic peptide and ANP fragments without initiating biological action. (05 Mar 2000) |
| p-aminohippurate clearance | A good measure of renal plasma flow, which it slightly underestimates; when a low plasma concentration of p-aminohippurate (PAH) is maintained by intravenous infusion, the kidney extracts and excretes almost all of the PAH from the plasma before it reaches the renal vein. (05 Mar 2000) |
| maximum urea clearance | The urea clearance when the urine flow exceeds 2 ml/min; normal value is about 75 ml blood/min per 1.73 m2 body surface area. (05 Mar 2000) |
| metabolic clearance rate | Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. (12 Dec 1998) |
| clearance | 1. The process of clearing. 2. <physiology> The rate at which a substance is removed from the blood. (18 Nov 1997) |
| mucociliary clearance | Rate of ciliary and secretory activity of the respiratory submucosal glands. It is a non-specific host defense mechanism, measurable in vivo by mucus transfer, ciliary beat frequency, and clearance of radioactive tracers. (12 Dec 1998) |
| creatinine clearance | Measurement of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate (GFR). (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|